Home / Without Label / SELB Selecta Biosciences Inc gains 27% Jan 24, 2020

Friday, January 24, 2020

SELB Selecta Biosciences Inc gains 27% Jan 24, 2020

priceSeries Friday, January 24, 2020 0 Comment

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company using its proprietary synthetic vaccine particle technology to discover & develop targeted therapies designed to modulate the immune system to treat rare and serious diseases.http://www.priceseries.com/trade/SELB-Selecta-Biosciences-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2020010320200124.html

Posted by : priceSeries Friday, January 24, 2020

No Comments

Subscribe to: Post Comments (Atom)